Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer.

导出 OA

翻译打印收藏纠错

作者： Swetlana,Gautam ^[1] ; Priyanka,Singh ^[1] ; Manjari,Singh ^[1] ; Subhadeep,Roy ^[1] ; Jitendra K,Rawat ^[1] ; Rajnish K,Yadav ^[1] ; Uma,Devi ^[2] ; Pushpraj S,Gupta ^[2] ; Shubhini A,Saraf ^[1] ; Gaurav,Kaithwas ^[1]

作者单位： Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University) Vidya vihar, Raebareli Road Lucknow-226 025 UP India gauravpharm@hotmail.com. ^[1] Department of Pharmaceutical Sciences, Faculty of Health Medical Sciences Indigenous and Alternative Medicine, SHIATS-Deemed to be University, Formerly Allahabad Agricultural Institute Naini Allahabad UP India. ^[2]

DOI 10.1039/c7ra09689e

PMID 35542911

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

RSC advances

2018年8卷7期

3512-3521页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer.

RSC advances

相似文献

RSC advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer.

RSC advances

相似文献

RSC advances

相关期刊

检索历史清除